GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReproCELL Incorp (TSE:4978) » Definitions » Net Income Including Noncontrolling Interests

ReproCELLorp (TSE:4978) Net Income Including Noncontrolling Interests : 円103 Mil (TTM As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is ReproCELLorp Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

ReproCELLorp's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2025 was 円134 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 was 円103 Mil.

ReproCELLorp Net Income Including Noncontrolling Interests Historical Data

The historical data trend for ReproCELLorp's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReproCELLorp Net Income Including Noncontrolling Interests Chart

ReproCELLorp Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only -813.62 -575.31 -305.31 -31.42 103.25

ReproCELLorp Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -79.75 -75.26 -28.96 73.18 134.29

ReproCELLorp Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円103 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ReproCELLorp Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of ReproCELLorp's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

ReproCELLorp Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReproCELL Incorp (TSE:4978) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
TSE:4588 TSE:190A TSE:7776 TSE:4880 TSE:4888 TSE:4579 TSE:4599 TSE:4584 TSE:4563 TSE:4583 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
6RC:Germany
Address
KDX Shin-Yokohama 381 Bldg. 9F, 3-8-11, Shin-Yokohama, Kohoku-ku, Kanagawa, Yokohama, JPN, 222-0033
Website
https://www.reprocell.com
ReproCELL Incorp is one of the leading stem cell research company in Japan. The company provides stem cell services, predictive drug discovery services, tissue services, and molecular services.

ReproCELLorp Headlines

No Headlines